Month: September 2017

One of the leading providers of energy infrastructure in the United States, Williams Partners L.P. WPZ is planning to develop its Transco interstate natural gas pipeline and has also filed an application with the Federal Energy Regulatory Commission (FERC) seeking approval for its Rivervale South to Market project. Per the certificate application, the expansion is expected to have a capital cost of $127 million […]

Of late, the finance sector has been performing well with some monthly volatility. The nation’s economic health, on which the sector is largely dependent, has been showing steady improvement with increasing real GDP numbers, declining unemployment rate, improving consumer spending and stabilizing housing market. […]

The U.S. Energy Department's weekly inventory release showed a below-average increase in natural gas supplies following which the commodity traded up. However, worries over the fuel’s tepid demand on the back of Tropical Storm Harvey-related power outages are expected to keep natural gas prices in check. […]

AMAG Pharmaceuticals, Inc. AMAG announced that the FDA accepted its submission for the label expansion of Feraheme (ferumoxytol). The label will include treatment of all adults with iron deficiency anemia (IDA) who have an intolerance or unsatisfactory response to oral iron […]

Over the years, Mexico, one of the biggest producers of petroleum and other liquids globally , has transitioned from being a net energy exporter to a net importer of energy. What Led to the Change? The import dependence was a result of the steady decrease in oil production that started in 2005 […]

The real estate investment trust (REIT) sector seems to be having a tough time due to the rising rate environment. In addition, new supply in certain asset categories and the rising trend of online purchases make the growth prospects bleak for the entire segment. Consecutive hike in the interest rates over the past three quarters has taken a toll on the profitability of REITs. […]

Incyte Corporation INCY announced that the European Society for Medical Oncology (ESMO) published an abstract containing new and updated data from the ongoing phase I/II ECHO-202 trial on epacadostat. The ECHO-202 study (NCT02178722) is evaluating the safety and efficacy of Incyte’s selective IDO1 enzyme inhibitor epacadostat in combination with Merck & Co.’s MRK Keytruda in patients with advanced melanoma. […]

Shares of Valeant Pharmaceuticals International, Inc . VRX have declined 7.6% so far in 2017 against 1.6% gain of the industry . Shares fell further 6.9% on Aug 29. […]

Lam Research LRCX shares have traded at a higher valuation than the S&P 500 and also the industry to which it belongs. But in 2016, the shares started widening this lead, a trend that has continued through 2017. […]

The U.S. chemical industry has gotten off to a buoyant start in the third quarter with July seeing a rise in chemical production on gains across all regions, according to the latest monthly report from the American Chemistry Council (ACC). […]

Parkinson’s disease (PD) is a progressive, degenerative neurological movement disorder resulting from the loss of dopamine-producing brain cells. The disease mainly progresses with age. […]

The insurance companies grapple with a volatile market condition, which includes regulatory reforms, rapidly changing climatic conditions and the palpable disagreement among the Fed officials over how quickly to raise interest rates. Given this scenario, picking the prospective winning stocks and making a prudent investment decision for the best returns may seem an uphill task. Interest Rates Rising — Apparent Boon? […]